In context
AOD-9604 is a modified fragment derived from growth hormone. Original studies include laboratory detection and metabolism work, and an osteoarthritis experiment in rabbits. [1–2]
At a glance
- Type
- Peptide / related experimental research
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- The rabbit study examined a joint-injury model, including combination treatment with hyaluronic acid. It does not establish human weight loss, joint recovery or a safe self-treatment regimen.
How to interpret this evidence
The rabbit study examined a joint-injury model, including combination treatment with hyaluronic acid. It does not establish human weight loss, joint recovery or a safe self-treatment regimen. [1] [2]
Safety and clinical context
The evidence described here does not establish safety for unsupervised use. Product identity, route, formulation, interactions and long-term effects cannot be inferred from a study category.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.
- Detection and in vitro metabolism of AOD9604. pubmed.ncbi.nlm.nih.gov
- Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. pubmed.ncbi.nlm.nih.gov